Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mutation informatics: SARS-CoV-2 receptor-binding domain of the spike protein
Saroj Verma, Vaishali M. Patil, Manish Gupta
Drug Discovery Today (2022) Vol. 27, Iss. 10, pp. 103312-103312
Open Access | Times Cited: 19

Showing 19 citing articles:

Promising Schiff bases in antiviral drug design and discovery
Shikha Kaushik, Sarvesh Paliwal, Malliga R. Iyer, et al.
Medicinal Chemistry Research (2023) Vol. 32, Iss. 6, pp. 1063-1076
Open Access | Times Cited: 61
Molecular Evolution of SARS-CoV-2 during the COVID-19 Pandemic
Luis Daniel González-Vázquez, Miguel Arenas
Genes (2023) Vol. 14, Iss. 2, pp. 407-407
Open Access | Times Cited: 30
Biophysics of SARS-CoV-2 spike protein’s receptor-binding domain interaction with ACE2 and neutralizing antibodies: from computation to functional insights
Fernando Luís Barroso da Silva, Karen Paco, Aatto Laaksonen, et al.
Biophysical Reviews (2025)
Closed Access | Times Cited: 1
A patent review of anti-coronavirus agents targeting the spike-ACE2 interaction (2019–present)
Xing Huang, Heng Gao, Jiwei Zhang, et al.
Expert Opinion on Therapeutic Patents (2025)
Closed Access
In Silico and In Vitro Analyses of Multiple Terpenes Predict Cryptotanshinone as a Potent Inhibitor of the Omicron Variant of SARS-CoV-2
Asmita Shrestha, Siddha Raj Upadhyaya, Bimal Kumar Raut, et al.
Processes (2024) Vol. 12, Iss. 1, pp. 230-230
Open Access | Times Cited: 3
Evaluation of humoral immune responses induced by different SARS‐CoV‐2 spike trimers from wild‐type and emerging variants with individual, sequential, and combinational delivered strategies
Chengchao Ding, Shuangshuang Ni, Xiangyu Zhang, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 12, pp. 5841-5849
Open Access | Times Cited: 9
In Silico Protein Structure Analysis for SARS-CoV-2 Vaccines Using Deep Learning
Yasunari Matsuzaka, Ryu Yashiro
BioMedInformatics (2023) Vol. 3, Iss. 1, pp. 54-72
Open Access | Times Cited: 4
Cheminformatics-Based Discovery of Potential Chemical Probe Inhibitors of Omicron Spike Protein
Salman Ali Khan, Alamgir Khan, Komal Zia, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 18, pp. 10315-10315
Open Access | Times Cited: 7
Extracellular vesicles in pulmonary infection: From pathophysiology to theranostic technologies
Xu Wang, Mai-Qing Shi, Yang Wang, et al.
Chemical Engineering Journal (2024) Vol. 498, pp. 155585-155585
Closed Access | Times Cited: 1
Ongoing evolution of SARS-CoV-2 drives escape from mRNA vaccine-induced humoral immunity
Alex Roederer, Yi Cao, Kerri St. Denis, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 12, pp. 101850-101850
Open Access | Times Cited: 1
Extracellular Vesicle-Based SARS-CoV-2 Vaccine
Yasunari Matsuzaka, Ryu Yashiro
Vaccines (2023) Vol. 11, Iss. 3, pp. 539-539
Open Access | Times Cited: 3
Kinetics of Drug Molecule Interactions with a Newly Developed Nano-Gold-Modified Spike Protein Electrochemical Receptor Sensor
Dingqiang Lu, Danyang Liu, Xinqian Wang, et al.
Biosensors (2022) Vol. 12, Iss. 10, pp. 888-888
Open Access | Times Cited: 4
Molecular Imaging of ACE2 Expression in Infectious Disease and Cancer
Zhiyao Li, A. Hasson, Lasya Daggumati, et al.
Viruses (2023) Vol. 15, Iss. 10, pp. 1982-1982
Open Access | Times Cited: 2
High-Throughput Molecular Dynamics-Based Alchemical Free Energy Calculations for Predicting the Binding Free Energy Change Associated with the Selected Omicron Mutations in the Spike Receptor-Binding Domain of SARS-CoV-2
Rajendra Bhadane, Outi M. H. Salo‐Ahen
Biomedicines (2022) Vol. 10, Iss. 11, pp. 2779-2779
Open Access | Times Cited: 3
Co-Mutations and Possible Variation Tendency of the Spike RBD and Membrane Protein in SARS-CoV-2 by Machine Learning
Qiushi Ye, He Wang, Fanding Xu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 4662-4662
Open Access
Molecular dynamics of SARS-CoV-2 omicron variants from Philippine isolates against hesperidin as spike protein inhibitor
June Alexis A. Santos, Searle S. Duay
Biophysical Chemistry (2024) Vol. 318, pp. 107387-107387
Closed Access
Association of Clinical Features with Spike Glycoprotein Mutations in Iranian COVID-19 Patients
Shahrzad Ahangarzadeh, Alireza Yousefi, Mohammad Mehdi Ranjbar, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 21, pp. 6315-6315
Open Access | Times Cited: 1
Role of Molnupiravir in the Treatment of COVID-19
Aman Sharma, Vaishali M. Patil, Meenakshi Dahiya, et al.
Anti-Infective Agents (2023) Vol. 21, Iss. 4
Closed Access
Development and Validation of In-vitro Release Study of Molnupiravir Capsules by RP-HPLC
Shipra Singhal, Aman Sharma, Anirudh Malik, et al.
Current Pharmaceutical Analysis (2023) Vol. 19, Iss. 7, pp. 577-585
Closed Access
Page 1

Scroll to top